Research & Development



  自從上次差點被皇帝五馬分尸,陳銅就變得小心謹慎了,騎在門框上監工的習慣也就養成了。   “吃根發炎的腸子就算有堅守?”免费的三级黄网站   雲瑯沖著曹襄獰笑道︰“你就當我是胡謅的。”曰本高清一本道无码av   桑弘羊連忙稟報道︰“七成!”   雲瑯停下采集桃膠的手,想了一下道︰“基本上沒法子,你老婆的潑婦性子已經不可逆轉了。”日本电影100禁在线看   莫非你連金銀也要一並廢除,將大漢國重新帶進以貨易貨的時代?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo